HFA Premium Access

Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction

Topic: HFpEF - Heart failure with preserved ejection fraction

Presentation

About the speaker

Doctor Antonella De Angelis

University of Campania Luigi Vanvitell, Naples (Italy)
1 presentation
0 follower

9 more presentations in this session

HFWM: Raf kinase inhibitor protein modulates interstitial and replacement cardiac fibrosis

Speaker: Doctor A. Kazakov (Homburg, DE)

Thumbnail

Aortic tissue proteomic profiling identifies the osmosignaling pathway components aquaporin-1 and tonicity binding protein as molecular biomarkers and mediators of vascular disease in diabetes

Speaker: Assistant Professor R. Madonna (Pisa, IT)

Thumbnail

Elamipretide (Bendavia, MTP-131) normalizes cGMP levels in left ventricular myocardium of dogs with advanced heart failure

Speaker: Professor H. Sabbah (Detroit, US)

Thumbnail

Role of intercellular adhesion molecule 1 in mediating pro-atherogenic and pro-fibrotic effects of mineralocorticoid receptor activation

Speaker: Doctor A. Armani (Rome, IT)

Thumbnail

Mechanical stretching on cardiac adipose progenitors upregulates sarcomere-related genes

Speaker: Doctor A. Llucia-Valldeperas (Amsterdam, NL)

Thumbnail

Access the full session

Moderated Poster Session 4 - Basic Science

Speakers: Doctor A. De Angelis, Doctor A. Kazakov, Assistant Professor R. Madonna, Professor H. Sabbah, Doctor A. Armani...
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk